Keywords: رالوکسیفن; Raloxifene; SERMs; Schizophrenia; Cognition; Menopause;
مقالات ISI رالوکسیفن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: رالوکسیفن; Raloxifene; SERM; Periodontitis; Postmenopausal osteoporosis;
Keywords: رالوکسیفن; Raloxifene; Postmenopause; Women; Schizophrenia; Meta-analysis;
Keywords: رالوکسیفن; Osteoporosis; Titanium-implant osseointegration; Synergistic administration; Raloxifene; Alendronate;
Keywords: رالوکسیفن; Breast cancer; Resveratrol; Raloxifene; Apoptosis;
Keywords: رالوکسیفن; Lacuna; Nanoindentation; Finite element model; Sequential treatment; PTH(1-34); Alendronate; Raloxifene;
Keywords: رالوکسیفن; Letrozole; Raloxifene; MCF-7; HEK; MTT;
Keywords: رالوکسیفن; Portal hypertension; Hepatic encephalopathy; Liver cirrhosis; Raloxifene;
Keywords: رالوکسیفن; Letrozole; Raloxifene; VCD; Micro CT; Bone turnover markers; Sclerostin and DKK-1;
Keywords: رالوکسیفن; Bisphosphonates; Denosumab; Raloxifene; Teriparatide; Atypical femoral fractures; Osteonecrosis of the jaw;
Keywords: رالوکسیفن; aging; aldehyde oxidase 1; autophagosome; DNA/RNA oxidation; fetal death; G-protein-coupled estrogen receptor 1; lipid oxidation; placenta; placental explant culture; raloxifene; stillbirth;
Keywords: رالوکسیفن; Estradiol; Raloxifene; Memory; Hippocampus; Gamma oscillations; Mice;
Keywords: رالوکسیفن; Androgen receptor; Bicalutamide; Castration resistant prostate cancer; Estrogen receptor; Prostate; Raloxifene;
Keywords: رالوکسیفن; Selective estrogen receptor down-regulator; ER-positive breast cancer; Raloxifene
Keywords: رالوکسیفن; Raloxifene; Negative symptoms; Schizophrenia; Genetics; Pharmacogenetics; Postmenopause;
Keywords: رالوکسیفن; Breast; Cancer; Fluoxetine; Raloxifene; Rats
Keywords: رالوکسیفن; Raloxifene; Melamine; Carbon nanoparticles; Modified electrodes; Voltammetry;
Keywords: رالوکسیفن; Raloxifene; SERM; Collagen; Bone powder
Keywords: رالوکسیفن; Aging; Osteoporosis; Strength training; Raloxifene; Bone microarchitecture
Keywords: رالوکسیفن; Raloxifene; Controlled drug release; Microsphere; Raloxifene-poly(ethylene glycol) conjugate; Poly(ε-caprolactone); Poly(D,L-lactide-co-glycolide)
Keywords: رالوکسیفن; Bone metabolism; estrogen; ovariectomized; periapical lesion; raloxifene
Keywords: رالوکسیفن; Breast cancer; Breast cancer prevention; Lobular carcinoma in situ; Tamoxifen; Raloxifene; Chemoprevention
Keywords: رالوکسیفن; Biomechanics; Osteoporosis; Fatigue testing; Bisphosphonate; Raloxifene; Metabolic acidosis
Keywords: رالوکسیفن; alendronate; raloxifene; osteoporosis
Keywords: رالوکسیفن; Raloxifene; Tamoxifen; Ovariectomy; Vascular reactivity; Cytokines;
Keywords: رالوکسیفن; AED; antiepileptic drug; BMD; bone mineral density; DEXA; dual energy X-ray absorptiometry; DG; dentate gyrus; E2; 17-β oestradiol; HRT; hormone replacement therapy; KA; kainic acid; OVX; ovariectomy; RLX; raloxifene; SE; status epilepticus; SERMs; selec
Keywords: رالوکسیفن; Whole body vibration; Osteoporosis; Fracture healing; Estrogens; Raloxifene;
Keywords: رالوکسیفن; Raloxifene; Schizophrenia; Cognitive function; Postmenopausal women
Keywords: رالوکسیفن; RAL; raloxifene; ALN; alendronate; RAL-4-Glu; raloxifene-4â²-glucuronide; RAL bis-Me; raloxifene bismethyl ether; Raloxifene; Mechanical testing; Toughness; Water;
Keywords: رالوکسیفن; drug delivery; triamcinolone; raloxifene; polycaprolactone; intra-articular applications; microspheres; site specific delivery; controlled release; polymeric biomaterials;
Keywords: رالوکسیفن; Estrogen Receptor; Androgen Receptor; Prostate Cancer; Di-indolyl methane; Raloxifene; Mifepristone; Telomerase;
Keywords: رالوکسیفن; Breast; Cancer; Cytotoxic activity; Raloxifene; Selenium; Selenophene;
Keywords: رالوکسیفن; APP; arterial pulse pressure; BMI; body mass index; DBP; diastolic blood pressure; Fmax syst; systolic maximum arterial flow; Fmed; mean arterial flow; HRT; hormone replacement therapy; MAP; mean arterial pressure; SBP; systolic blood pressure; SERMs; sel
Keywords: رالوکسیفن; Decision aids; Tamoxifen; Raloxifene; Breast cancer prevention; Tailoring;
Keywords: رالوکسیفن; BMD; bone mineral density; BZA; bazedoxifene; CE; conjugated estrogens; EPT; estrogen-progestin therapy; ER; estrogen receptor; LAS; lasofoxifene; LDL-C; low-density lipoprotein cholesterol; MCF-7; Michigan Cancer Foundation-7; MENQOL; Menopause-Specific
Keywords: رالوکسیفن; BMD; bone mineral density; SERM; selective estrogen receptor modulator; MA; metabolic acidosis; CONT; control; RAL; raloxifene; ZOL; zoledronate; Sup; Superficial; Int; Intermediate; Ctr; Central; HA; hydroxyapatite; SHG; second harmonic generation; FTIR;
NiO nanoparticle decorated on single-wall carbon nanotubes and 1-butyl-4-methylpyridinium tetrafluoroborate for sensitive raloxifene sensor
Keywords: رالوکسیفن; NiO/SWCNTs; Raloxifene; 1-Butyl-4-methylpyridinium tetrafluoroborate; Sensor;
Poly(methyl vinyl ether-co-maleic acid) for enhancement of solubility, oral bioavailability and anti-osteoporotic effects of raloxifene hydrochloride
Keywords: رالوکسیفن; Electrospray; Raloxifene; Solubility enhancement; Poly(methyl vinyl ether maleic acid); Oral delivery; Ovariectomized rats;
Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort
Keywords: رالوکسیفن; breast cancer; chemoprevention; raloxifene; risk; tamoxifen;
Raloxifene, a promising estrogen replacement, limits TDP-25 cell death by enhancing autophagy and suppressing apoptosis
Keywords: رالوکسیفن; ALS; amyotrophic lateral sclerosis; CCK-8; Cell Counting Kit-8; CTF25; C-terminal fragment-25; TDP-43; TAR DNA-binding protein 43; Ral; raloxifene; E2; 17β-estradiol; SERMs; selective estrogen receptors; ER; estrogen receptor; GPR30; G-protein coupled re
Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells
Keywords: رالوکسیفن; Osteoblast; Osteoclast; Alkaline phosphatase; Raloxifene; Lasofoxifene; Puerarin;
The Combination of GIS and Biphasic to Better Predict In Vivo Dissolution of BCS Class IIb Drugs, Ketoconazole and Raloxifene
Keywords: رالوکسیفن; ASD; GIS; ketoconazole; raloxifene; BCS class II drug; simulation; in vivo performance;
Bazedoxifene and raloxifene protect neocortical neurons undergoing hypoxia via targeting ERα and PPAR-γ
Keywords: رالوکسیفن; Bazedoxifene; Raloxifene; SERMs; Hypoxia; Neocortical neurons; Neuroprotection; PPAR-γ; Estrogen receptors;
Raloxifene microsphere-embedded collagen/chitosan/β-tricalcium phosphate scaffold for effective bone tissue engineering
Keywords: رالوکسیفن; Bone tissue engineering; Raloxifene; Scaffold; Chitosan; Collagen;
Solid dispersions of drugs in hyaluronan matrix: The role of the biopolymer in modulating drug activity in vivo
Keywords: رالوکسیفن; Hyaluronic acid; Solid dispersion; Raloxifene; Letrozole; Irinotecan; Pharmacokinetics;
Original articleThe selective estrogen receptor modulators (SERMs) raloxifene and tamoxifen improve ANP levels and decrease nuclear translocation of NF-kB in estrogen-deficient rats
Keywords: رالوکسیفن; Ovariectomy; SERMs; Raloxifene; Tamoxifen; ANP; NF-kB;
New treatment paradigm of combined raloxifene and conjugated estrogen for postmenopausal symptoms in VCD-induced menopausal rats
Keywords: رالوکسیفن; Raloxifene; Estrogen; Osteoporosis; Vulvar/vaginal atrophy;
Inhibition of IL-6/STAT3 signaling in human cancer cells using Evista
Keywords: رالوکسیفن; Raloxifene; STAT3; Breast cancer; Colon cancer; Multiple myeloma;
A comparative in vitro release study of raloxifene encapsulated ordered MCM-41 and MCM-48 nanoparticles: A dissolution kinetics study in simulated and biorelevant media
Keywords: رالوکسیفن; Raloxifene; MCM-41-NP; MCM-48-NP; Simulated dissolution media; Biorelevant dissolution media; Dissolution kinetics;
Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene
Keywords: رالوکسیفن; hTERT; Cyclin D1; Transcription signature; Raloxifene; PX-866